Genetic relatedness of multidrug-resistant Escherichia coli cultured from geographically diverse outpatient, midstream urine specimens

Diagnostic Microbiology and Infectious Disease

Volumn 58, Issue 3, 2007, Pages 283-287

  Karlowsky, James A ^a,b   Kasloff, Sam ^b   Nichol, Kim A ^a   Hoban, Daryl J ^a,b   Zhanel, George G ^b  

^a Diagnostic Services of Manitoba Inc   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Escherichia coli; Multi drug resistant; Pulsed field gel electrophoresis; Urine

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; GENOMIC DNA; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATE; ESCHERICHIA COLI; FEMALE; GEOGRAPHIC DISTRIBUTION; GRAM NEGATIVE INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NONHUMAN; OUTPATIENT; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; URINARY TRACT INFECTION; URINE CULTURE;

AMBULATORY CARE; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GEOGRAPHY; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; URINARY TRACT INFECTIONS; URINE;

EID: 34347351908     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.01.012     Document Type: Article

References (21)

1. Burman W.J., Breese P.E., Murray B.E., Singh K.V., Batal H.A., MacKenzie T.D., Ogle J.W., Wilson M.L., Reves R.R., and Mehler P.S. Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates. Am. J. Med. 115 (2003) 358-364
2. Carrico J.A., Pinto F.R., Simas C., Nunes S., Sousa N.G., Frazao N., de Lencastre H., and Almeida J.S. Assessment of band-based similarity coefficients for automatic type and subtype classification of microbial isolates analyzed by pulsed-field gel electrophoresis. J. Clin. Microbiol. 43 (2005) 5483-5490
3. Centers for Disease Control and Prevention. One-Day (24-48 h) Standardized Laboratory Protocol for Molecular Subtyping of Escherichia coli 0157:H7 by Pulsed Field Gel Electrophoresis (PFGE) (2001), Centers for Disease Control and Prevention, Atlanta, GA
4. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement, M100-S15, vol. 25, no. 1 (2005), Clinical and Laboratory Standards Institute, Wayne, PA
5. France A.M., Kugeler K.M., Freeman A., Zalewski C.A., Blahna M., Zhang L., Marrs C.F., and Foxman B. Clonal groups and the spread of resistance to trimethoprim-sulfamethoxazole in uropathogenic Escherichia coli. Clin. Infect. Dis. 40 (2005) 1101-1107
6. Gupta K., Hooten T.M., and Stamm W.E. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann. Intern. Med. 135 (2001) 41-50
7. Johnson J.R. Virulence factors in Escherichia coli urinary tract infections. Clin. Microbiol. Rev. 4 (1991) 80-128
8. Johnson J.R., Manges A.R., O'Bryan T.T., and Riley L.W. A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis. Lancet 359 (2002) 2249-2251
9. Karlowsky J.A., Kelly L.J., Thornsberry C., Jones M.E., and Sahm D.F. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob. Agents Chemother. 46 (2002) 2540-2545
10. Karlowsky J.A., Thornsberry C., Jones M.E., and Sahm D.F. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Clin. Infect. Dis. 36 (2003) 183-187
11. Karlowsky J.A., Hoban D.J., DeCorby M.R., Laing N.M., and Zhanel G.G. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study. Antimicrob. Agents Chemother. 50 (2006) 2251-2254
12. Manges A.R., Johnson J.R., Foxman B., O'Bryan T.T., Fullerton K.E., and Riley L.W. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N. Engl. J. Med. 345 (2001) 1007-1013
13. Manges A.R., Natarajan P., Solberg O.D., Dietrich P.S., and Riley L.W. The changing prevalence of drug-resistant Escherichia coli clonal groups in a community: evidence for community outbreaks of urinary tract infections. Epidemiol. Infect. 134 (2006) 425-431
14. National Committee for Clinical Laboratory Standards. Abbreviated Identification of Bacteria and Yeast; Approved Guideline, M35-A. vol. 22 no. 18 (2002), National Committee for Clinical Laboratory Standards, Wayne, PA
15. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, M7-A6. vol. 23 no. 2. 6th ed. (2003), National Committee for Clinical Laboratory Standards, Wayne, PA
16. Nicolle L.E. Epidemiology of urinary tract infection. Infect. Med. 18 (2001) 153-162
17. Petrof E.O., Schwartz D.N., and Quinn J.P. Urinary tract infections and a multidrug-resistant Escherichia coli clonal group. N. Engl. J. Med. 346 (2002) 535-536
18. Phillips I., Eykyn S., King A., Gransden W.R., Rowe B., Frost J.A., and Gross R.J. Epidemic multiresistant Escherichia coli infection in West Lambeth Health District. Lancet 1 (1988) 1038-1041
19. Sahm D.F., Thornsberry C., Mayfield D.C., Jones M.E., and Karlowsky J.A. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob. Agents Chemother. 45 (2001) 1402-1406
20. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., and Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33 (1995) 2233-2239
21. Zhanel G.G., Hisanaga T.L., Laing N.M., DeCorby M.R., Nichol K.A., Palatnick L.P., Johnson J., Noreddin A., Harding G.K.M., Nicolle L.E., Hoban D.J., and the NAUTICA Group. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 26 (2005) 380-388